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Abstract
Emerging evidences indicate that blood platelets function in multiple biological processes 
including immune response, bone metastasis and liver regeneration in addition to their known 
roles in hemostasis and thrombosis. Global elucidation of platelet proteome will provide the 
molecular base of these platelet functions. Here, we set up a high throughput platform for 
maximum exploration of the rat/human platelet proteome using integrated proteomics 
technologies, and then applied to identify the largest number of the proteins expressed in both rat 
and human platelets. After stringent statistical filtration, a total of 837 unique proteins matched 
with at least two unique peptides were precisely identified, making it the first comprehensive 
protein database so far for rat platelets. Meanwhile, quantitative analyses of the thrombin-
stimulated platelets offered great insights into the biological functions of platelet proteins and 
therefore confirmed our global profiling data. A comparative proteomic analysis between rat and 
human platelets was also conducted, which revealed not only a significant similarity, but also an 
across-species evolutionary link that the orthologous proteins representing ‘core proteome’, and 
the ‘evolutionary proteome’ is actually a relatively static proteome.
Keywords
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1 Introduction
Platelets are anucleate cells that derive from megakaryocytes and circulate in the blood 
stream [1, 2]. Under normal conditions, platelets help maintain vascular integrity through 
their involvement in clot formation and repair of injury [3]. Meanwhile, disregulated 
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platelets were found to contribute to pathological consequences such as many types of 
cardiovascular diseases which are the most common causes of mortality in modern society 
[1]. For example, arterial thrombosis appearing as the abnormal formation of clots is a major 
factor in developing heart attacks [4].
While many functional aspects of platelets have been investigated for centuries [5, 6], the 
growing line of evidences have been suggesting there are more functions of platelets yet to 
be explored [7-11]. For instance, platelets have recently been found to act as the immune 
and signaling cells in inflammation and innate immune responses [3, 12]. Under 
lipopolysaccharide (LPS) stimulation, platelets may express functional toll-like receptor 4 
(TLR4) [7]. The interplay between platelets and neutrophils after TLR4 expression leads to 
the rapid formation of neutrophil extracellular traps (NETs) that can entrap and kill bacteria 
[8]. Blood platelets can also contribute to cancer metastasis [6, 13]. Platelets activated by the 
releasate from tumors may adhere to cancerous cells and form a shield that protects tumor 
cells from removal by the immune system [6]. Platelets may also facilitate metastasis by 
assisting circulating tumor cells to adhere to vascular tissues and move out of the vessel [6, 
14, 15]. Furthermore, as platelets have no nuclei, they represent a simplified model for the 
study of signal-dependent protein transcription and programmed cell death [2, 9]. A recent 
study suggested that Bcl-xL triggers Bak mediated apoptosis in platelets [2]. Surprisingly, 
platelets have also been shown to play a remarkable role in liver regeneration [10].
Taken together of all these evidences, a global exploration of the platelet proteome, a yet 
still largely unknown treasure chest, represents a critical step to provide the molecular basis 
for understanding the multi-functional nature of platelets. Importantly, the characterization 
of those platelet proteins involved in discrete facets of physiological functions will reveal 
possible biomarkers for early diagnosis of the progression of certain diseases including 
cardiovascular diseases and cancers [16, 17].
Mass spectrometry (MS)-based proteomics technologies provide powerful approaches for 
profiling of particular proteomes including the expressed/secreted proteins in platelets [18, 
19]. However, due to trade-offs involving sensitivity, accuracy, and throughput for each type 
of separation/identification scheme, it is difficult to obtain a relatively complete proteome by 
using a single separation/identification approach [20]. Remarkably, a prestigious group 
reported a global profiling of the membrane and cytosolic proteome of human red blood 
cells (RBCs) using combined protein identification technologies [21]. Furthermore, a direct 
comparison with mouse RBCs on the proteome level was also carried out, which indicated 
close concordance between the two proteomes [22]. Most recently, a cross-species 
comparison of Caenorhabditis elegans with fruitfly Drosophila melanogaster at the proteome 
level was performed, which illustrated their analogous proteins have similar relative 
amounts, even though the mRNA levels vary widely between the two species [23].
Here, we presented an integrated platform including multi-step protein extraction, 
multidimensional separation/identification approaches, and combined mass spectra 
interpretation algorithms to obtain the maximum coverage of both rat and human platelet 
proteome. To examine the functional relevance of our datasets, one of the popular labeling 
strategies, isobaric tags for relative and absolute quantitation (iTRAQ), was also used. In 
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order to understand the mutual and diverse proteome between these closely related 
mammals, a comparative proteome analysis was conducted, which suggested the function 
diversity of platelet proteome for the first time.
2 Materials and methods
2.1 Vital platelet isolation from rat and human blood
Fresh blood obtained from healthy rats was placed into plastic tubes containing acid/citrate/
dextrose (ACD) antigoagulant (70 mM citric acid, 85 mM sodium citrate, 110 mM glucose) 
[24]. The subsequent isolation was carried out as previously reported [25]. Minor 
modifications included altering the ratio between ACD buffer and blood volume, multiple 
steps but higher centrifugation speed to avoid any potential contaminants from red blood 
cells (RBCs), and different but compatible lysis buffer for subsequent MS analysis. Briefly, 
5 mL ACD buffer were added into 10mL fresh blood, and this increased ratio could 
successfully prevent potential precipitation [24]. After centrifugation at 200×g for 20 
minutes, the upper two-thirds of the platelet-rich plasma (PRP) was carefully collected 
followed by 12 minutes centrifugation at 1000×g [26]. The platelet pellets on the bottom of 
the tube were gently collected, then resuspended in Tyrodes buffer and washing buffer 
described previously [24]. After 1 hour incubating at room temperature, the platelets were 
spun down again at 1000×g for 12 minutes to eliminate some fragments of RBCs. The 
platelet pellets were then subjected to protein extraction and drawn into ACD buffer to 
prevent precipitation. Similar procedures as described above were then applied to isolate 
blood platelets. Based on the procedures described above, human platelets were prepared 
from fresh blood of healthy volunteers who had not been on medication for the previous ten 
days. Use of human blood was approved by the ethics committee of the Fudan University 
and informed consent was granted by the donors.
2.2 Thrombin stimulation of vital platelets
The platelets freshly isolated from rat blood following the above procedures were re-
suspended in 2mL Tyrodes buffer to the final concentration of 1×109 cells/mL. 100μL 
stimulation solution (1 unit thrombin, 20 mM CaCl2, 20 mM MgCl2 in Tyrodes buffer) was 
added to stimulate the platelets for 3 min at 37°C. The platelets were washed and pelleted at 
5000×g for 3 min, and the supernatant was removed.
2.3 Protein extraction, SDS PAGE separation, and in-solution/in-gel digestion
An optimized two-step strategy was carried out to extract platelet proteins. Firstly, the 
platelet pellets obtained from rat and human blood were added into 8M urea to extract 
water-soluble proteins (Extraction I). After 30 minutes incubation on ice, the lysate was 
centrifuged at 15,000 rpm for 15 minutes. Half of the Extraction I was subjected to in-
solution digestion after diluting the urea concentration to lower than 2M. The remaining 
proteins were subjected to IEF separation. The pellet debris was incubated for 30 minutes on 
ice in a second lysis buffer (7M urea, 2M thiourea, 2% CHAPS, 15 μL protease inhibitor, 
100mM fresh-made DTT) to obtain Extraction II. Then no visible insoluble debris was left 
in the tube. Extracted proteins were then separated by SDS PAGE under a standard protocol 
[27]. About 200 μg Extraction II were loaded into 2 parallel lanes of a homemade 12% SDS-
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PAGE gel. After coomassie blue staining, the gel was cut into 14 continuous sections 
(Supplement Figure 1), diced into small pieces and placed in 1-mL Eppendorf tubes. In-gel 
digestion and peptide extraction were performed using common protocol [27].
2.4 Isoelectric focusing (IEF) separation
Urea-extracted proteins were resuspended in a modified IPG buffer that contained only 3-10 
pH nonlinear IPG buffers (Amersham Bioscience), so harmful contaminations of the 
CHAPS detergent and bromophenol blue dye were intentionally avoided [28]. The protein 
solution was then applied to an 18 cm 3-10 nonlinear Immobiline DrySrip (Amersham 
Bioscience) according to the manufacture's procedure.
Similarly, IEF separation of peptides was carried out on the in-solution digested peptides 
using similar IPG strip. The focusing protocol was slightly different from the IEF of 
proteins. Excess cover oil was carefully removed, and the strip was cut into 24 equal 
sections within 3 minutes to avoid potential diffusion [29]. As for proteins on the strip, in-
gel digestion was carried out as described previously [27]. For peptides on the strip, a series 
of sequential extractions was performed as described elsewhere [28].
2.5 Liquid chromatography and mass spectrometry
Two dimensional liquid chromatography tandem mass spectrometry (2D LC MS/MS) 
approach involved an LTQ Orbitrap mass spectrometer (Thermo Electron) in connection 
with an LC Packings Ultimate chromatography system (LC Packings Ultimate System, 
Dionex, CA). Peptides were bounded to a strong cation exchange (SCX) column (15 cm×4.6 
mm, 5 μm, 300Ǻ, PolyLC) and eluted with eight sequential injections of ammonium acetate 
solutions with various concentrations (0, 50, 100, 200, 400, 800, 1000, 2000 mM), which 
was followed by a 2-hour reversed phase gradient (15 cm×300 μm column, 5μm C18, LC 
Packings) to further separate the peptides containing in each elution step. Mobile phase A 
was 0.1% formic acid (FA) in 5% acetonitrile (ACN). Mobile phase B was 0.1% FA in 95% 
ACN. Gradient parameters: 0-10 minutes, 10%B; 10-90 minutes, 40%B; 90-110 minutes, 
90%B; 110-120 minutes, 0%B. The 1D LC separations was performed on the same LC 
system mentioned above or a Micromass CapLC Pump (Waters, UK). The column and 
gradient settings were almost the same as described above except some minor changers in 
the column equilibration time in the Micromass CapLC.
Tandem MS (MS/MS) analysis was performed on the LTQ Orbitrap or QTOF (Micromass, 
QTOF API-US, Waters, UK) mass analyzer. The five most intense ions fully scanned by 
Orbitrap (resolution is 60000 at m/z 400, scan range is from m/z 300 to 2000) were 
sequenced in the LTQ. Ion charge state screening was enabled and all the singly charged 
species were rejected. For QTOF, mass spectra were acquired in positive mode over the 
range m/z 400-1900. The top four most-abundant precursors were selected for MS/MS 
analysis using 38V cone voltage.
2.6 Database searching and protein identification
All raw MS data was searched against the rat International Protein Index (IPI) protein 
database (version 3.07) using the Mascot (version 2.0; Matrix Science, London, UK) and 
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Sequest search engines (ThermoFisher Scientific, CA), respectively. All the “.raw” files 
acquired from LTQ Orbitrap were converted to “.mgf” (Mascot Generic Format) files using 
the Trans Proteomic Pipeline (TPP) platform[30] to make them compatible with Mascot. 
The merged “.mgf” files from different salt fractions of 2D LC experiments were then 
submitted to a 64 bite dualprocessor server in the UNC-Duke Michael Hooker Proteomics 
Center (http://proteomics.unc.edu). The Sequest search engine is an in-house cluster with 
72.2-Ghz dual processor nodes.
For protein assignment, positive identifications were made based on stringent filters. In the 
case of Sequest engine, the ΔCn values for all matched peptides were set higher than 0.1, 
and the cross-correlation scoring (XCorr) thresholds were at least 1.90 (z=2), 2.70 (z=3), 
and 3.11 (z=4) according to the reversed database search evaluation and the ensured false 
discovery rate (FDR) was less than 0.05. Additionally, the computed probability through 
TPP tools[30] must be higher than 0.95 for each matched peptide. Protein assignments were 
only made if the protein had at least two unique peptides passing the criteria mentioned 
above. As for the Mascot search engine, all assigned peptides should be in the first rank and 
then filtered by the peptide score originating from reversed database searching (34 for the 
QTOF-based analyses, 41 for the others). To further eliminate redundant proteins matched 
with the same set of peptides (group proteins), a stringent interpretation method was 
employed, thus leading to a minimized dataset. In brief, proteins that span the same set of 
peptides, or a subset, were collapsed into one representative protein, which has the max hits 
or shortest sequence length [31, 32].
2.7 iTRAQ labeling of platelet peptides, and iTRAQ-based quantitative analysis of 
thrombin-induced proteome changes in vital platelets
The proteins extracted from both non-stimulated and thrombin-stimulated platelets were 
treated with tris-(2-carboxyethyl) phosphine (TCEP) and iodoacetamide, in-solution 
digested with trypsin and then labeled with an isobaric tag reagent according to the 
manufacturer's protocol (Applied Biosystems, Foster City, CA). The above two samples 
were equally mixed and separated using an off-line 2D SCX-RPLC approach. The LC 
conditions were similar to those used in on-line 2DLC separation described above, except 
that the samples were washed 30 min using loading buffer (10 mM KH2PO4 in 25% ACN at 
pH 3.0) before the salt elution in order to remove detergents and excess reagents.[33] Eight 
salt plugs (25, 37.5, 50, 75, 100, 125, 150, 175, 200, and 350 mM KCl at pH 3.0) were 
injected sequentially and peptide fractions were collected, lyoplized and then cleaned using 
PepClean C18 spin column (Pierce, Rockford, IL).
LC-MS/MS analyses were performed on a nanoflow LC Packings System (Dionex, CA) 
interfaced to a QSTAR Elite Hybrid mass spectrometer (Applied Biosystems). Peptides 
were separated at a flow rate of 200 nL/min over a C18 column (15 cm×75 μm column, 5μm 
particle size, LC Packings) using an identical 2-hour gradient described above. MS scans 
were acquired in a data-dependant mode from m/z 300 to 2000 and up to three most intense 
parent ions were selected for MS/MS scan.
ProteinPilot (version 2.0.1, Revision 67476, Applied Biosystems) with the Paragon 
Algorithm was used for the identification and quantification of relative abundance of platelet 
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proteins expressed in different pathological conditions. All the MS/MS spectra were 
searched against the NCBI protein database using the following criteria: 95% confidence for 
protein identification, trypsin cleavage specificity, methyl methanethiosulfonate (MMTS) as 
the defined modification.
3 Results and Discussion
3.1 Integrated platform maximizes the coverage of MS-detectable platelet proteome
When a single MS-based proteomic approach is taken trade-offs involving the sensitivity, 
accuracy, and throughput often made in profiling proteins with diverse physical properties. 
To identify maximum numbers of the platelet proteins with different pI and hydrophobicity, 
variable expressions in a wide dynamic range, etc, our current platform integrates multiple 
components including a two-step protein extraction approach, multiple gel-based and gel-
free separation methods in a complimentary manner, and different MS analysis strategies 
(Figure 1).
First, the two-step extraction protocol was used to recover most of the proteins from the 
purified platelets. In contrast to the common extraction methods, such as repeated freeze-to-
thaw cycling and acetone precipitation, which collect soluble proteins and normally discard 
the undissolved parts, our method could recover most of the platelet proteins which ensured 
a comprehensive starting material [22, 34, 35]. Secondly, the subsequent gel-based and gel-
free separation methods were chosen for the proteins extracted from different lysis buffers 
accordingly. The proteins in surfactant-based lysis buffer were loaded onto the SDS gel. 
Then the CHAPS detergents, which are notoriously incompatible with RPLC-MS/MS, were 
removed. Meanwhile, the proteins extracted from surfactant-free lysis buffer were 
introduced to IPG strip and digested in solution, respectively. Thus the resulted peptides 
were compatible with the following RPLC-MS/MS approach because urea was readily 
removed by reversed phase column without pretreatment [36]. Finally, both mass 
spectrometers, LTQ Orbitrap and QTOF, were used in the integrated platform to overcome 
the intrinsic weakness of each type of the instruments used alone [20].
As summarized in Table 1, a total of 837 rat platelet proteins were identified in high 
confidence, including 320 proteins identified by the gel-free 2DLC-LTQ Orbitrap approach 
and 634 proteins (with redundancy) detected by SDS PAGE-RPLC-LTQ Orbitrap approach. 
As a widely used pre-separation method, SDS PAGE could effectively fractionate a complex 
sample, meanwhile, it provides a molecular size window for the proteins of interest [21]. 
The identified proteins are then readily validated using Western blotting [37]. On the other 
hand, two dimensional strong cation exchange-reverse phase liquid chromatography (2D 
SCX-RPLC) approach which is based on the property orthogonality of a variety of peptides 
is also routinely used by most proteomics labs [38]. Recent data showed that the above two 
approaches are comparable with respect to the number of identified proteins [39]. 
Interestingly, our data indicated the SDS PAGE-RPLC-LTQ MS/MS identified more 
proteins than those identified by SCX-RPLC-LTQ approach. One of the possible reasons is 
the former approach (14 gel bands) has more fractions than the latter one (7 salt plugs) in the 
first dimensional separation, which resulted in higher resolution in separation and more 
protein identifications.
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The overall identified proteins were grouped into 6 and12 classes with respect to their 
subcellular localization and biological function. As shown in Figure 2A & 2C, about 26% of 
the identified proteins were known as cytoskeleton and membrane proteins, and more than 
40% proteins were related to cell organization and transportation, which was consistent with 
the fundamental roles of platelets in clot formation and wound healing. Meanwhile, up to 
23% proteins had the known function directly related to protein metabolism. According to 
previous findings [21], red blood cells (RBC) have a large number of membrane and 
cytosolic proteins involving in cellular metabolism, probably due to the relatively short life 
span of RBCs, which requires fast degradation of organelles or macromolecules [21]. In 
contrast, platelets have an even shorter life span and may undergo programmed cell death, 
typically after a week in the blood stream [40]. Therefore, this distribution pattern of 
functional categories of our identified platelet protein is reasonable. Furthermore, some 
proteins (4%) were classified as nucleus proteins. Given that platelets are anucleate, these 
proteins probably derived from megakaryocytes during thrombopoiesis [16, 41].
Interestingly, one of the newly identified human platelet proteins, Calumenin [42], which is 
responsible for the activation of coagulation protein (such as matrix Gla protein, MGP),[43] 
was unambiguously identified in the rat platelets. Calumenin was identified in human 
atherosclerotic lesions but not in normal vasculature, which indicated a potential role in 
atherosclerosis and thrombosis formation [42]. In our recent study of the rat platelet 
proteome changes during diethyl nitrosamine (DEN)-induced tumor progression in the 
mouse liver, calumenin was found to be closely associated with the inflammation or 
cirrhosis status of the rat liver (Leng TH, et al, unpublished results).
3.2 Minimal contaminations from other blood cells was assayed to ensure a precise profile 
of platelet proteome
The purity of the isolated platelets was examined by microscopic inspection and only the 
platelets with 99.9% purity were used for our profiling experiments [26]. Imaging was also 
performed in a standard scanning electron microscope to confirm the absence of potentially 
contaminating leukocytes and erythrocytes (data not shown). In general, our platelet sample 
contained less than 1 red or white blood cell per 10 000 platelets. Furthermore, as the well-
known and highly abundant nucleus proteins, either histones or histone fragments were not 
found, suggesting minimum contamination of nucleated blood cells [44]. The absence of the 
abundant erythrocyte protein ankyrin in our identification profile also suggested that 
possible contamination from RBCs was ignorable. However, some representative proteins 
from RBCs were identified in the rat platelets, such as hemoglobin α/β chain and Spectrin 
α/β chain,[21] suggesting their potential expressions in rat platelets [44, 45]. In comparison 
with the published results of human platelets, our protocol of preparing highly purified 
platelets ensured the data accuracy and consistency of rat or human platelet proteome and 
made it possible to perform comparison analysis of rat and human platelet proteome based 
on the same proteomic platform.
3.3 Proteomes with high dynamic range were detected by using the integrated platform
We utilized a semi-quantitation analysis tool, the exponentially modified protein abundance 
index (emPAI) which proved to be effective in human cancer cell proteome [46, 47], to 
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estimate the relative abundance of our identified platelet proteins. All emPAI indexes were 
calculated through the exponentially modified number of observed peptides divided by the 
number of observable peptides for each individual protein [48]. As a result, the relative 
abundance of 837 rat platelet proteins was quantified by emPAI. According to the order of 
emPAI, these proteins were classified as low (emPAI<0.1 and without emPAI annotated), 
medium (0.1≤emPAI<1) and high (emPAI≥1) abundance proteins, respectively. The number 
of proteins in each category was 86 for low-abundance, 624 for medium-abundance, and 127 
for high-abundance, respectively. All the quantitative information of the overall proteins was 
presented in Supplementary Table 1.
According to the semi-quantitative analysis, more than 72% of low-abundance proteins and 
61% of medium-abundance proteins were detected by a single approach (Figure 3), which 
implicated the necessity of combined approaches. But for high-abundance proteins, more 
than 54% were detected by at least two approaches; moreover, 13% were detected by all five 
approaches. For instance, thrombospondin 1 (TSP1), defined as a highly abundant protein by 
emPAI index (emPAI=1.183), was identified by all five approaches mentioned above. TSP1 
is secreted from platelet α-granules and interacts with collagens and fibrinogen in the 
extracellular matrix [49]. So, modulation of activity of various thrombospondins might be 
therapeutically effective [50]. In our study, the correlation between protein abundance and 
the number of approaches used in combination coincided well. The combination of multiple 
strategies was effective to identify maximum numbers of the proteins expressed in a wide 
dynamic range.
By using this integrated platform, we also identified six isoforms of 14-3-3 proteins in rat 
platelets, ε, τ, γ, β/α, ζ/δ and η. Even through there are seven known mammalian isoforms 
(14-3-3σ is expressed in epithelial cells only) [51], only five of them have been previously 
found in human platelets, which contain high levels of the ζ, β, and γ isoforms and lower 
levels of the ε and η [52]. By using the integrated approach, we detected almost all the 
14-3-3 isomers with varied abundance in rat platelets.
3.4 Combination of multiple search engines provided more protein identifications
We also demonstrated that the coverage of the MS-detectable platelet proteome could be 
dramatically improved when MS/MS spectra were analyzed with multiple search algorithms 
in a complementary way, which was in agreement with previous reports [20]. For the spectra 
acquired by using LTQ Orbitrap, a total of 7241 peptides were assigned by either Mascot or 
Sequest (Figure 4A); 55% of them were confirmed by both search engines, 16% were 
exclusively interpreted by Sequest and 29% by Mascot, respectively. The overlap in our 
studies was slightly different from the previous study [20], in which 68% of the assigned 
spectra were matched by dual search engines, 22% and 9% were exclusively matched by 
Mascot and Sequest, respectively. Considering the complexity of large-scale protein 
composition in platelets, such diversity suggested that the combination of multiple search 
engines can be exploited to increase the coverage of protein identification for a proteome.
Notably, one more interesting finding can also be illustrated in terms of the relationship 
between the search engines and protein-abundance distributions (Figure 4B). For highly 
abundant proteins, more than 70% were assigned by both search engines with extremely 
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high confidence. This percentage dramatically decreased for low-abundance proteins as only 
43% could be confirmed by both engines, indicating that single algorithm is not sufficient 
enough to assign each spectrum with proper protein entries, especially those low abundance 
proteins. Furthermore, we also found that Sequest matched more low-abundance proteins 
than Mascot. On the contrary, the exclusive identifications from Mascot were significantly 
higher than those from Sequest for high-abundance proteins. Due to the inherent nature of 
these two different algorithms, the probability-based algorithm, Mascot, may be more 
sensitive than the empirical and correlative measurements provided by Sequest. Thereby, the 
complementary use of dual search engines and algorithms was helpful in obtaining a higher 
coverage of platelet proteome.
3.5 The quantitative analysis of the thrombin-inducible proteins in the MS-identified 
platelet proteome further validates the accuracy of our platelet proteome dataset
Given the fact that the response to thrombin stimulation is a characteristic function of 
platelets, we reason the expression of those platelet-characteristic proteins should be 
thrombin-inducible. Therefore, by using thrombin to stimulate the rat platelets we examined 
the functional relevance of our platelet proteome dataset and further analyzed the accuracy 
of our identification of platelet proteins. We then applied iTRAQ-based quantitative 
proteomic approach to identify those proteins showing the thrombin-inducible changes in 
their expressions. Through iTRAQ-labeling the paired stimulated versus non-stimulated 
platelets were analyzed through a 2D-LC-MS/MS approach. In total, 415 non-redundant 
proteins were confidently identified in more than 3 duplicated runs. Using the thresholds 
previously set [53], i.e. 20% abundance changes or the isotope ratio larger than 1.2 or 
smaller than 0.8, measured by iTRAQ signal peaks, the expression level of 16 proteins in the 
profile of identified platelet proteins were found elevated while 17 proteins in the profile 
showed decreased expression level (Supplementary Table 6).All of these differentially 
expressed proteins were classified according to the biological processes and pathways using 
PANTHER classification system (http://www.pantherdb.org/).
As shown in Figure 5, most of the thrombin-inducible proteins were related to metabolic 
processes wherein over 50% of them were directly involved in protein metabolism and 
modifications, also many of them were involved in the household metabolisms for 
nucleotide or carbohydrate, or fatty acid, etc. This observation suggested the metabolic 
activities in platelets were enhanced following thrombin stimulation. Another prominent 
group of the thrombin-inducible proteins were related to cell structure and motility and 
intracellular protein trafficking, which was unsurprising in accordance with the known 
physiological role of activated platelets. For instance, through a study using a knockout 
mouse model calpain-1 was found as a positive regulator in platelet aggregation and clot 
retraction [54]. Our quantitative proteomics data indicated that upon thrombin stimulation 
calpain-1 was found up-regulated by 1.4 fold. Meanwhile, the thrombin-inducible proteins 
are linked to a variety of signaling pathways including blood coagulation, apoptosis, integrin 
signaling pathway and toll receptor signaling pathway. Furthermore, a EF-hand domain 
containing 2 (EFHD2) protein was recently found involving in protein synthesis in the 
encephalomyelitis (EAE) rats with autoimmune diseases[55]. Although the role of EFHD2 
in platelets and its contribution to thrombin stimulation remain undefined, we found the 
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expression level of EFHD2 was up-regulated by 1.5 fold upon stimulation, a sign indicating 
that protein synthesis may occur in platelets after thrombin treatment. Calpain 1 is one of the 
ubiquitously expressed isoforms of calpain family, which is a highly conserved group of 
intracellular calcium-dependent cysteine proteases[56, 57]. Calpain 1 was shown to be part 
of the integrin signal-transduction apparatus. It associates with focal adhesion proteins in 
platelets and regulates the attachment of αIIbβ3 to the cytoskeleton[57]. Recent evidences 
suggested that inhibition of calpain using overexpressed calpastatin (its highly specific 
endogenous inhibitor) prevents thrombin-stimulated α-granule secretion and platelet 
aggregation[58]. While we have identified this protein in the resting platelets, the expression 
of calpain 1 was also found up-regulated by 1.4, which is in line with the previous finding of 
its function in platelets. Apolipoprotein E (ApoE) was previously known to inhibit platelet 
aggregation through the L-Arginine:Nitric Oxide Pathway[59]. In our quantitative analysis, 
ApoE indeed showed a trend of down-regulation following thrombin activation, i.e., with an 
iTRAQ ratio < 0.7. Tubulin is the major component of microtubules which are involved in 
numerous processes such as cell division and migration[60]. In an effort to characterize its 
function, the mice lacking β1-tubulin was found to produce approximately 60% less platelets 
than their wild-type littermates, and these platelets show an attenuated response to 
thrombin[61]. While the responses of β2- and β5-tubulin to thrombin stimulation are still 
unknown, our results indicated that these two tubulin isoforms were down-regulated after 
thrombin stimulation.
In general, because thrombin is a characteristic stimulus which activates platelets, all 
thrombin-induced differentially expressed proteins were found in our dataset of platelet 
proteome, suggesting the accurate content of functionally related platelet proteome 
identified by our proteomic platform.
3.6 Generation of a human platelet proteome database and comparison with the rat platelet 
proteome
We have combined some of the platelet datasets available so far with our human proteomic 
dataset to construct a comprehensive human platelet protein database. Those datasets 
derived from pathological, toxicological or pharmacological platelet samples or individual 
protein analysis was not included in the final list. As a result, 1053 human platelet proteins 
were summarized from several reported results (Supplementary Table 2) [44, 62-65]. After 
comparison with our database, 114 novel proteins candidates were confidently identified 
using our integrated strategies (Supplementary Table 3 and 4).
A global analysis on the proteome level of the rat and human platelets was then performed, 
which mainly focused on physicochemical characteristics including hydrophobicity (HP) 
and pI distribution[66] and Gene Ontology (GO) annotations [67, 68]. Firstly, HP and pI 
distributions showed almost the same patterns (Supplementary Figure 3). According to 
previous findings[69], the multi-modality of pI distribution is a common feather in several 
known proteomes (e.g. E.coli, C. elegans, H. sapiens and M. musculus)[70]. Our data 
confirmed the modality, furthermore, revealed that the protein pIs in a sub-proteome or a 
specific organelle also follows the similar tend. The subcellular localization and functional 
distribution patterns (Figure 2) also showed high similarities between rat and human platelet 
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proteins. To highlight the comparative profile, two more tissues, human plasma and heart 
(Supplementary S1, Supplementary Figure 4 and 5), were introduced into the analysis. 
Biologically, it was not surprising that the protein localization and functions showed clear 
tissue-specific distributions. No significant species-specific differences were observed 
between the human and rat platelet proteins.
Furthermore, we performed the pathway mapping analysis in comparison with human and 
rat platelet proteins as all identified platelet proteins were mapped to the pathway database 
by using a bioinformatics platform of KEGG (Kyoto Encyclopedia of Genes and Genomes) 
[71], which allows user input genes on static pathway maps generated by BioCarta and 
KEGG with correspondingly calculated p-value [72]. The pathways were ranked in the order 
of the number of mapped platelet proteins. The top 10 mapped pathways in human platelet 
were then compared with those mapped in rat platelets (Table 2). Eight of the top 10 
significantly mapped pathways in human platelets were also found in the top 10 pathways in 
rat, except for the proteasome and apoptosis pathway. The high similarity between human 
and rat with minimal differences was a reflection of platelet evolution: ‘the stable core, and 
the variable shell’ [73].
3.7 Comparison of orthologous proteins
Orthologs are sequences of genes that evolved from a common ancestor and can be traced 
evolutionarily across different species [73]. Highly conserved sequences may suggest 
similar functions that are regulated by similar biochemical pathways and playing similar 
roles in different species [73, 74]. Therefore, with the availability of the rat and human 
platelet proteome, it is now possible to use orthologous proteins to inspect proteome 
evolution between species and to annotate newly discovered proteins.
In the present study, based on the OrthoMCL database which contains the grouped ortholog 
protein sequences in a genome-scale across different species [75, 76], we extracted all 
orthologous pairs from human and rat platelet proteome. Such highly conserved protein sets 
represented the essential function and structural similarities of platelets between both 
species. As shown in Figure 6A, 386 orthologous pairs were found in human and rat platelet 
datasets, including 327 and 346 unique orthologous proteins for human and rat, respectively. 
According to the semi-quantitative results, more than 58% of orthologous pairs were high 
abundant, which indicated that the abundant proteins also play some fundamental roles even 
though they're almost always discarded by proteomics researchers. Furthermore, all 
orthologous proteins were categorized according to their subcellular localizations, molecular 
functions and cellular processes as mentioned above (Figure 6B and C). At least two 
interesting conclusions could be made according to the comparison of the orthologous with 
overall proteins. First, the distribution patterns based on localization and function of 
orthologous proteins were coincident with the distributions of the global profiles of platelet 
proteins (Figure 2). This raised the possibility that orthologous proteins represent the ‘core 
proteome’ within different species, which could conduct almost all the fundamental 
functions in platelets; second, the orthologous proteins in each category have similar 
percentages (versus the overall proteins in the same group, Figure 6D and E). These 
relatively even distributions (percentage of subcellular localizations, 48.0%±8.5%; 
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percentage of molecular functions, 46.2%±8.6%) of orthologs in each locational and 
functional group provide us with new knowledge of natural selection, if any, that the 
‘evolutionary proteome’ is a type of static proteome.
4 Concluding remarks
Due to the abundance-based nature of MS-based proteomics approaches, we selected rat as 
the model species for obtaining much more materials of platelets. Actually, compared with 
mouse, rat is a pathologically relevant model for investigating human cardiovascular disease 
[77, 78]. Meanwhile, rat platelet proteome hasn't been fully investigated yet since the 
availability of rat genome sequence from 2004 [79]. Here, we integrated a variety of 
approaches including multi-step protein extraction, various combinations of 
multidimensional LC-MS/MS schemes, and two MS/MS spectra interpretation algorithms to 
maximum the coverage of the rat platelet proteome. This integrated platform, validated by 
its successful application to the human platelets study, provided the scientific community an 
experimental and informational resource, especially a high quality rat platelet protein 
database and a combined human platelet protein database. Impressively, the newly 
constructed human platelet protein database demonstrated multidimensional information and 
new insights not visible within a single data set [80]. The first global comparison of human 
and rat platelet proteomes presented interesting knowledge of evolutionary proteomics, 
revealed some important features of basic cellular processes, and thus improve our 
understanding of the anucleated platelet proteins conserved among mammals. The data also 
show significant similarities between the rat and human platelet proteins, which highlights 
the use of the rat model for studying platelet-related thrombosis and cardiovascular diseases. 
Although our analysis of the platelet proteome was conducted for the resting state of 
platelets, our profiling datasets served as a starting point for molecular understanding the 
complex functions of platelets in mammals [80].
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Schematic illustration of rat and human platelet proteome analysis
A two-step extraction method with 8M urea and the lysis buffer was applied to extract 
platelet proteins for either SDS gel-based separation and LC-MS/MS or in-solution digestion 
respectively.
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(A & B) Radar plots illustrating the distribution of protein subcellular localization from rat 
and human platelets. Proteins belonging to Other locations were not shown in the radar plots 
(rat, 20.3%; human, 29.6%). ER, endoplasmic reticulum. (C & D) Radar plots showing the 
categories of molecular functions and biological processes of the proteins identified in the 
rat and human platelets.
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Figure 3. The distribution of quantified proteins versus the number of matched approaches used
Low, emPAI<0.1 and without emPAI annotated; medium, 0.1≤emPAI<1; high, emPAI≥1.
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Figure 4. Results of the database search using dual engines including Mascot and Sequest
The Venn plot demonstrates the overlap and exclusive matched proteins or peptides of 
MASCOT and SEQUEST. The number of peptides or proteins was marked in the 
corresponding areas. (B) The histogram shows the matched ratios of search engines in each 
abundance category. All of the peptides and proteins were confirmed through bioinformatics 
analysis.
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Figure 5. Biological process (A) and pathway (B) analyses of the differentially expressed proteins 
after thrombin stimulation
Metabolism group (in A) and other pathways group (in B) were further classified into 7 and 
11 groups, respectively, according to the bioinformatics analysis results.
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Figure 6. Bioinformatics analysis of orthologous proteins
(A) The Venn plot (left) demonstrates the orthologous proteins between human and rat 
platelets. (B, C) All orthologous proteins in rat platelets are classified according to their 
subcellular localization and molecular functions. (D, E) The histogram demonstrates the 
ratios of the orthologous proteins in each category versus the overall proteins in the same 
category. The dotted lines show the average value of the distributions.
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